New Zealand markets close in 4 hours 35 minutes

Lixte Biotechnology Holdings, Inc. (8640.F)

Frankfurt - Frankfurt Delayed price. Currency in USD
Add to watchlist
0.0000-6.1000 (-100.00%)
At close: 08:57AM CEST
Currency in

Valuation measures4

Market cap (intra-day) 5.61M
Enterprise value 4.11M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)21.24
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.72

Trading information

Stock price history

Beta (5Y monthly) -0.23
52-week change 3-24.69%
S&P500 52-week change 328.04%
52-week high 38.5500
52-week low 34.6000
50-day moving average 36.1000
200-day moving average 36.0910

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 52.25M
Implied shares outstanding 62.25M
Float 81.98M
% held by insiders 120.48%
% held by institutions 16.07%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 305 Jun 2023

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-64.47%
Return on equity (ttm)-111.07%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-5.09M
Diluted EPS (ttm)-3.3900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.2M
Total cash per share (mrq)1.87
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)13.73
Book value per share (mrq)0.22

Cash flow statement

Operating cash flow (ttm)-4.29M
Levered free cash flow (ttm)-2.4M